Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms
Andrea Schmitt, Daniel Martins‐de‐Souza, Schahram Akbarian, et al.
The World Journal of Biological Psychiatry (2016) Vol. 18, Iss. 5, pp. 330-356
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Changing trends in the global burden of mental disorders from 1990 to 2019 and predicted levels in 25 years
Yang Wu, Lu Wang, Mengjun Tao, et al.
Epidemiology and Psychiatric Sciences (2023) Vol. 32
Open Access | Times Cited: 60
Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings
Lukasz Smigielski, Vinita Jagannath, Wulf Rössler, et al.
Molecular Psychiatry (2020) Vol. 25, Iss. 8, pp. 1718-1748
Closed Access | Times Cited: 134
HDAC1 links early life stress to schizophrenia-like phenotypes
Sanaz Bahari‐Javan, Hristo Varbanov, Rashi Halder, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 23
Open Access | Times Cited: 96
BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review
Rodrigo Nieto, Andrea Carrasco, Sebastián Corral, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 64
Biological hypotheses, risk factors, and biomarkers of schizophrenia
Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110626-110626
Closed Access | Times Cited: 60
Alteration of microRNA expression in lymphocytes in patients with first-episode schizophrenia
Jingjing Huang, Xuyi Wang
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Transdiagnostic Extension of Delusions: Schizophrenia and Beyond
Paul Bebbington, Daniel Freeman
Schizophrenia Bulletin (2017) Vol. 43, Iss. 2, pp. 273-282
Open Access | Times Cited: 68
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets
Vincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108279-108279
Closed Access | Times Cited: 30
Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia
Isabel Maurus, Alkomiet Hasan, Astrid Röh, et al.
European Archives of Psychiatry and Clinical Neuroscience (2019) Vol. 269, Iss. 5, pp. 499-515
Closed Access | Times Cited: 54
Clinical Staging in Psychiatry
Patrick D. McGorry, Patrick D. McGorry, Patrick D. McGorry, et al.
Cambridge University Press eBooks (2019)
Closed Access | Times Cited: 51
Formin 2 links neuropsychiatric phenotypes at young age to an increased risk for dementia
Roberto Carlos Agís‐Balboa, Paulo S. Pinheiro, Nelson Rebola, et al.
The EMBO Journal (2017) Vol. 36, Iss. 19, pp. 2815-2828
Open Access | Times Cited: 49
Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stress
Melanie Föcking, Sophie Sabherwal, Hannah M. Cates, et al.
Molecular Psychiatry (2019) Vol. 26, Iss. 2, pp. 524-533
Open Access | Times Cited: 48
Peripheral Biomarkers for First-Episode Psychosis—Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia
Nuno Trovão, Joana Prata, Orlando von Doellinger, et al.
Psychiatry Investigation (2019) Vol. 16, Iss. 3, pp. 177-184
Open Access | Times Cited: 44
Subtypes of schizophrenia identified by multi-omic measures associated with dysregulated immune function
Chunyan Luo, Xuenan Pi, Na Hu, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 11, pp. 6926-6936
Closed Access | Times Cited: 35
Schizophrenia: A Narrative Review of Etiopathogenetic, Diagnostic and Treatment Aspects
Laura Orsolini, Simone Pompili, Umberto Volpe
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5040-5040
Open Access | Times Cited: 25
Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis
Manuel Morrens, Livia De Picker, Jarl K. Kampen, et al.
Schizophrenia Research (2020) Vol. 223, pp. 43-52
Closed Access | Times Cited: 29
Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders
Аnastasia Levchenko, Timur Nurgaliev, Alexander Kanapin, et al.
Heliyon (2020) Vol. 6, Iss. 5, pp. e03990-e03990
Open Access | Times Cited: 22
The role of genetic variation of human metabolism for BMI, mental traits and mental disorders
Johannes Hebebrand, Triinu Peters, Dick Schijven, et al.
Molecular Metabolism (2018) Vol. 12, pp. 1-11
Open Access | Times Cited: 17
Association between dynamic resting-state functional connectivity and ketamine plasma levels in visual processing networks
Marie Spies, Manfred Klöbl, Anna Höflich, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 17
Enhanced Molecular Appreciation of Psychiatric Disorders Through High-Dimensionality Data Acquisition and Analytics
Jaana van Gastel, Jhana O. Hendrickx, Hanne Leysen, et al.
Methods in molecular biology (2019), pp. 671-723
Closed Access | Times Cited: 14
The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism
George E. Jaskiw, Mark E. Obrenovich, Curtis J. Donskey
Psychopharmacology (2019) Vol. 236, Iss. 5, pp. 1471-1489
Closed Access | Times Cited: 12
Controversies in psychiatry
Florence Thibaut
Dialogues in Clinical Neuroscience (2018) Vol. 20, Iss. 3, pp. 151-152
Open Access | Times Cited: 12
Variability of DNA Methylation within Schizophrenia Risk Loci across Subregions of Human Hippocampus
W. Brad Ruzicka, Sivan Subburaju, Francine M. Beneš
Genes (2017) Vol. 8, Iss. 5, pp. 143-143
Open Access | Times Cited: 11
Transcranial sonography in psychiatry as a potential tool in diagnosis and research
Carsten Drepper, Julia Geißler, Giuseppe Pastura, et al.
The World Journal of Biological Psychiatry (2017) Vol. 19, Iss. 7, pp. 484-496
Closed Access | Times Cited: 10
“Now Is a Time for Optimism”: The Politics of Personalized Medicine in Mental Health Research
Jonas Rüppel
Science Technology & Human Values (2019) Vol. 44, Iss. 4, pp. 581-611
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top